13F filer · CIK 1422848 ↗
Capital Research Global Investors
You are looking at Q3 2023. See the latest, Q2 2026 →
Reported value
$363.16B
−2.7% on the quarter before
Positions
411
20 new · 23 sold out
Top 10
27.4%
of the value
Est. gain
−$10.46B
on stocks held all quarter
Est. return
−3.0%
on those stocks since Q2 2023
Positions as of Sep 30, 2023, from Capital Research Global Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 45% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2023. Striped tiles are options.
Largest buys
Since Q2 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Texas Instruments~$1.65BAdded · 0.8% → 1.2%+10,364,260 shares
- Uber~$1.32BNew · 0.0% → 0.4%+28,763,300 shares
- Meta~$1.20BAdded · 1.7% → 2.1%+4,006,394 shares
- United Rentals Inc~$1.02BAdded · 0.3% → 0.6%+2,290,708 shares
- Union Pac Corp~$957.1MAdded · 0.0% → 0.3%+4,700,090 shares
- Seagate Technology Hldngs Pl~$786.7MNew · 0.0% → 0.2%+11,929,430 shares
- Thermo Fisher Scientific Inc~$699.1MAdded · 0.9% → 1.0%+1,381,152 shares
- Tc Energy Corp~$684.5MAdded · 0.3% → 0.4%+19,904,339 shares
- Cenovus Energy Inc~$578.4MAdded · 0.7% → 1.0%+27,781,526 shares
- Chubb Limited~$555.9MAdded · 0.1% → 0.3%+2,670,479 shares
Largest sells
Since Q2 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Netflix~$2.57BCut · 2.1% → 1.1%−6,817,578 shares
- Amazon~$1.34BCut · 3.4% → 3.1%−10,564,074 shares
- Sea~$1.16BCut · 0.6% → 0.1%−26,492,407 shares
- Stryker Corporation~$1.10BCut · 1.2% → 0.8%−4,017,483 shares
- Micron~$1.01BCut · 0.9% → 0.7%−14,875,310 shares
- Baker Hughes~$978.8MCut · 0.8% → 0.6%−27,712,708 shares
- Broadcom~$966.4MCut · 4.5% → 4.1%−1,163,578 shares
- General Electric Co~$929.5MCut · 2.7% → 2.6%−8,407,756 shares
- Altria Group Inc~$908.6MCut · 0.4% → 0.2%−21,607,509 shares
- Snowflake~$682.4MCut · 0.5% → 0.2%−4,466,823 shares
Holdings
As of Sep 30, 2023. Changes are in shares against Jun 30, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares +2.2% · price −7.3% | 6.5% | $23.70B | −$1.82B | ||||||||
| BroadcomCOM · shares −6.1% · price −4.2% | 4.1% | $14.99B | −$664.8M | ||||||||
| AmazonCOM · shares −11% · price −2.5% | 3.1% | $11.13B | −$283.6M | ||||||||
| General Electric CoCOM NEW · shares −9.1% · price +0.6% | 2.6% | $9.30B | +$58.9M | ||||||||
| MetaCL A · shares +18% · price +4.6% | 2.1% | $7.74B | +$288.1M | ||||||||
| Abbott LabsCOM · shares +2.4% · price −11.2% | 2.1% | $7.66B | −$939.7M | ||||||||
| Unitedhealth Group IncCOM · shares +2.7% · price +4.9% | 2.1% | $7.46B | +$339.3M | ||||||||
| AlphabetCAP STK CL A · shares +3.1% · price +9.3% | 1.8% | $6.69B | +$553.2M | ||||||||
| Canadian Nat Res LtdCOM · shares −3.6% · price +15.0% | 1.6% | $5.74B | +$750.8M | ||||||||
| Rtx CorporationCOM · shares +9.8% · price −26.5% | 1.4% | $5.26B | −$1.73B | ||||||||
| MastercardCL A · shares −11% · price +0.7% | 1.4% | $5.15B | +$34.0M | ||||||||
| Carrier GlobalCOM · shares +8.0% · price +11.0% | 1.4% | $4.96B | +$456.7M | ||||||||
| Philip Morris Intl IncCOM · shares +3.9% · price −5.2% | 1.4% | $4.96B | −$259.8M | ||||||||
| Abbvie IncCOM · shares −1.7% · price +10.6% | 1.3% | $4.77B | +$458.2M | ||||||||
| Eog Res IncCOM · shares +6.9% · price +10.8% | 1.3% | $4.60B | +$418.0M | ||||||||
| AlphabetCAP STK CL C · shares +3.5% · price +9.0% | 1.3% | $4.60B | +$366.8M | ||||||||
| AppleCOM · shares +14% · price −11.7% | 1.2% | $4.45B | −$519.3M | ||||||||
| Linde PlcSHS · shares −0.8% · price −2.3% | 1.2% | $4.45B | −$104.2M | ||||||||
| Texas InstrumentsCOM · shares +61% · price −11.7% | 1.2% | $4.36B | −$358.5M | ||||||||
| Gilead Sciences IncCOM · shares +0.02% · price −2.8% | 1.2% | $4.34B | −$123.3M | ||||||||
| Comcast Corp NewCL A · shares −1.4% · price +6.7% | 1.2% | $4.29B | +$270.2M | ||||||||
| Home Depot IncCOM · shares +7.3% · price −2.7% | 1.1% | $4.16B | −$108.8M | ||||||||
| NetflixCOM · shares −39% · price −14.3% | 1.1% | $4.03B | −$670.4M | ||||||||
| Eli LillyCOM · shares +6.9% · price +14.5% | 1.1% | $3.90B | +$462.3M | ||||||||
| Cenovus Energy IncCOM · shares +18% · price +22.6% | 1.0% | $3.81B | +$595.0M | ||||||||
| Total · 411 positions | 100% | $363.16B | −$10.46B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2023 to Q3 2023: 390 stocks held throughout, down $10.46B (−3.0%).
- Canadian Nat Res Ltd+$750.8M+15%
- Cenovus Energy Inc+$595.0M+23%
- Alphabet+$553.2M+9%
- Eli Lilly+$462.3M+15%
- Abbvie Inc+$458.2M+11%
- Insulet Corp−$666.3M−45%
- Netflix−$670.4M−14%
- Abbott Labs−$939.7M−11%
- Rtx Corporation−$1.73B−27%
- Microsoft−$1.82B−7%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $716.87B+11% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $644.56B+19% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $541.73B+2% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $532.97B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $499.46B+9% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $459.90B−5% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $486.38B+1% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $481.14B+6% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $455.74B+3% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $441.98B+9% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $406.47B+12% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $363.16B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $373.18B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $350.40B+6% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $330.88B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $304.37B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $321.05B−21% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $405.10B−11% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $452.67B+6% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $428.65B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $429.52B+5% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $408.71B+6% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $385.30B+16% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $333.11B+5% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $316.13B+24% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $254.90B−24% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $333.48B+9% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $304.85B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $314.99B−0% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $315.45B+10% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $287.02B−17% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $344.02B−6% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $366.12B+4% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $351.43B+3% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $340.76B+3% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $331.24B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $319.49B+1% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $317.04B+3% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $308.47B+2% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $302.53B+3% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $292.47B+1% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $290.06B | SEC ↗ |